I prefer diversified high risk, high reward investing. Biotechs are a current favorite. In 2014, up 34.5% (117 times the S&P), and Stocktwits is a big reason. Happy with the result, but still cautious.
Dropout from a Computer Science and a Psychology degree. since the age of 18, I have worked with many reputable Fortune 100 companies. I couldn't imagine to be where I'm at without following "the saying"
battle-tested trader/investor since 1996. Managing Partner Rosemarkie Capital Partners, managed a Barron's recognized small cap newsletter. By day, a Director of Software Engineering at a firm in Northern VA.